Ondansetron
Product Images NDC 70934-448

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 70934-448). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (70934 448 83 Master Bottle Label Approval Rev A 04 20)

Label (70934 448 83 Master Bottle Label Approval Rev A 04 20)
Ondansetron Orally Disintegrating Tablets 8mg, 4 tablets per pack, labeled for oral disintegration. The label includes storage instructions (20°–25°C controlled room temperature), dosage notes to see package insert, and warnings to keep out of reach of children. Manufactured by Denton Pharma, Inc. DBA Northwind Pharmaceuticals with NDC 70934-448-83. The label also features barcode and lot number fields.*
FDA Label Image

Ondansetron-structure (Ondansetron Structure)

Ondansetron-structure (Ondansetron Structure)
Chemical structure of ondansetron. The image depicts the molecular structure with characteristic benzene and heterocyclic rings as part of the ondansetron molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.